​Dynorphin A (1-13) Acetate CAS NO.CAS 72957-38-1

​Dynorphin A (1-13) Acetate CAS NO.CAS 72957-38-1

​Dynorphin A (1-13) Acetate  CAS NO.CAS 72957-38-1

​Dynorphin A (1-13) Acetate CAS NO.CAS 72957-38-1

​Dynorphin A (1-13) Acetate CAS NO.CAS 72957-38-1

Dynorphin A (1-13) Acetate (CAS 72957-38-1) is a synthetic peptide fragment derived from the endogenous opioid peptide Dynorphin A. This 13-amino acid sequence retains the core biological activity of the full-length peptide, serving as a potent and selective kappa-opioid receptor (KOR) agonist. Supplied as a high-purity white to off-white lyophilized powder, it is an essential research tool for neuroscience, pain research, and psychopharmacology studies. With verified receptor binding affinity and comprehensive analytical documentation, our product ensures reliable performance for investigating opioid signaling pathways, stress responses, and neuropsychiatric mechanisms.


TECHNICAL SPECIFICATIONS


Item
Specification
Product Name
Dynorphin A (1-13) Acetate
CAS NO.
72957-38-1
Appearance
White to off-white lyophilized powder
Molecular Formula
C75H126N24O15
Molecular Weight
1603.98 g/mol 
Purity (RP-HPLC)
≥ 95.0%
Solubility

Soluble in water, dilute acetic acid, and PBS buffer; may require gentle vortexing

Endotoxin< 1.0 EU/mg
Biological Activity
Endogenous opioid peptide; selective κ-opioid receptor agonist with analgesic and neuroregulatory effects.
Storage Conditions
Store at -20°C, protected from light and moisture. After reconstitution, aliquot and store at -20°C.
Stock Location
Stock in USA
MOQ
1g


1.MECHANISM OF ACTION

Dynorphin A (1-13) Acetate functions as a selective agonist for kappa-opioid receptors (KOR) in the central and peripheral nervous systems. Upon binding, it activates Gi/o protein-coupled signaling pathways, leading to inhibition of adenylate cyclase, reduced cAMP production, and modulation of ion channel activity. This action results in hyperpolarization of neurons, decreased neurotransmitter release (particularly dopamine in the mesolimbic pathway), and modulation of pain perception, stress responses, and emotional processing.


2.PRODUCT INDICATIONS

Neuroscience Research: Investigation of kappa-opioid receptor function, signaling pathways, and neural circuitry
Pain Mechanism Studies: Research on endogenous pain modulation and analgesic systems
Psychopharmacology: Studies of stress responses, addiction mechanisms, and mood regulation
Neuropsychiatric Research: Investigation of depression, anxiety, and reward processing disorders
Drug Discovery: Screening and development of novel kappa-opioid receptor-targeted therapeutics


3.CLINICAL EFFICACY OF PRODUCT

Receptor Specificity: High selectivity for kappa-opioid receptors with minimal cross-reactivity to mu- and delta-opioid receptors
Biological Activity: Verified analgesic and anti-stress effects in validated animal models
Research Reliability: Consistent performance in receptor binding assays and functional studies
Scientific Validation: Supported by extensive literature on dynorphin physiology and opioid pharmacology
Quality Assurance: ≥95% HPLC purity with comprehensive analytical characterization
Technical Support: Available data on receptor binding constants and functional activity profiles


4.DELIVERY & SHIPPING

We specialize in global logistics for various cosmetic peptides. Your order will be handled with the utmost care, ensuring safe, reliable, and intact delivery.
Professional and Secure Packaging
Each bottle of peptide is protected with a special packaging solution to ensure stability and integrity during transportation.
We can also customize packaging according to customer needs.
Shipping Methods 
Main Method: International Air Freight

We primarily use DHL, FedEx, UPS, and TNT because of their global reliability, speed, and advanced tracking systems. Air freight ensures the fastest transit time and minimizes the impact of environmental factors on the product.

High Purity Neurotensin Analogs and Exemestane Class Probes
Jul 06, 26
High Purity Neurotensin Analogs and Exemestane Class Probes
The pharmaceutical landscape is constantly evolving, with a significant focus on the development of highly specific ligands to decode complex biological systems. Within this context, the study of the exemestane class of research toolsspecifically high-purity peptide analogsplays a pivotal role in understanding receptor-mediated signaling. By utilizing precise molecular modifications, researchers can now probe the intricacies of the neurotensin system with unprecedented accuracy. Globally, the demand for specialized research probes has surged as medicinal chemistry shifts toward rational drug design. The ability to modulate binding affinity and selectivity between receptor subtypes is no longer a luxury but a necessity
Industrial Purity of Juice WATER pNA and exemestane 25 mg bodybuilding
Jul 03, 26
Industrial Purity of Juice WATER pNA and exemestane 25 mg bodybuilding
The landscape of biochemical analysis has been significantly transformed by the introduction of high-precision substrates, a field where the concept of exemestane 25 mg bodybuilding often appears in search queries despite the stark difference between clinical aromataze inhibitors and laboratory reagents. In the realm of pharmaceutical manufacturing and food science, the ability to quantify protease activity with absolute precision is paramount for maintaining product stability and quality. Understanding the mechanism of chromogenic substrates allows researchers to bridge the gap between raw biochemical data and commercial application.
Understanding the Therapeutic Role of exemestane drug class
Jul 01, 26
Understanding the Therapeutic Role of exemestane drug class
Understanding the Exemestane Drug Class and Its Therapeutic Role In the realm of endocrine therapy for breast cancer, identifying the correct exemestane drug class is critical for optimizing patient outcomes. Exemestane belongs to a specialized group of medications designed to inhibit the production of estrogen, which fuels the growth of hormone-receptor-positive breast cancers. Unlike earlier generations of hormone therapies, this class offers a more direct approach to enzymatic inhibition. By targeting the final step of estrogen synthesis, it provides a robust mechanism for managing postmenopausal oncology cases. Understanding the nuances of this pharmacological category allows researchers and clinicians to better navigate

If you are interested in our products, you can choose to leave your information here, and we will be in touch with you shortly.